We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

204 hedge funds and large institutions have $2.2B invested in Bio-Rad Laboratories Class A in 2014 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 57 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

691% more call options, than puts

Call options by funds: $1.8M | Put options by funds: $227K

50% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 22

40% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 57

6% more funds holding

Funds holding: 193 → 204 (+11)

1.25% more ownership

Funds ownership: 76.44% → 77.69% (+1.2%)

4% less capital invested

Capital invested by funds: $2.31B → $2.2B (-$101M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
204
Holders Change
+11
Holders Change %
+5.7%
% of All Funds
5.86%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
33
Increased
80
Reduced
57
Closed
22
Calls
$1.8M
Puts
$227K
Net Calls
+$1.57M
Net Calls Change
+$1.28M

Top Buyers

1
Norges Bank
Norges Bank
Norway
+$18.9M
2
RRAM
River Road Asset Management
Kentucky
+$14.2M
3
TSW
Thompson Siegel & Walmsley
Virginia
+$14M
4
NFA
Nationwide Fund Advisors
Ohio
+$12.2M
5
NIMC
NWQ Investment Management Company
California
+$11M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$24.4M
2
TM
Tikvah Management
North Carolina
-$12.2M
3
KCM
Kennedy Capital Management
Missouri
-$10.9M
4
First Trust Advisors
First Trust Advisors
Illinois
-$8.15M
5
RA
Royce & Associates
New York
-$7.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASRS
101
Arizona State Retirement System
Arizona
$1.63M +$36.6K +300 +2%
BG
102
BlackRock Group
United Kingdom
$1.62M -$147K -1,202 -8%
MOACM
103
Mutual of America Capital Management
New York
$1.49M -$12.9K -106 -0.8%
AAM
104
Advisors Asset Management
Colorado
$1.47M +$562K +4,602 +60%
MAM
105
Martingale Asset Management
Massachusetts
$1.43M +$256K +2,100 +21%
SG Americas Securities
106
SG Americas Securities
New York
$1.37M +$1.07M +8,732 +321%
HHC
107
Hutchin Hill Capital
New York
$1.3M +$1.33M +10,900 New
New York State Teachers Retirement System (NYSTRS)
108
New York State Teachers Retirement System (NYSTRS)
New York
$1.29M – – –
ProShare Advisors
109
ProShare Advisors
Maryland
$1.18M +$876K +7,176 +272%
Invesco
110
Invesco
Georgia
$1.14M +$378K +3,097 +48%
SOMRS
111
State of Michigan Retirement System
Michigan
$1.14M – – –
ARTA
112
A.R.T. Advisors
New York
$1.05M +$1.07M +8,801 New
Bank of Montreal
113
Bank of Montreal
Ontario, Canada
$1.01M -$1.34K -11 -0.1%
N
114
Nuveen
North Carolina
$992K +$24.1K +197 +2%
Royal Bank of Canada
115
Royal Bank of Canada
Ontario, Canada
$982K +$778K +6,369 +347%
FA
116
FDx Advisors
Illinois
$960K +$244 +2 +0%
DT
117
Diversified Trust
Tennessee
$946K +$965K +7,905 New
GMIM
118
General Motors Investment Management
New York
$884K +$902K +7,387 New
Verition Fund Management
119
Verition Fund Management
Connecticut
$818K +$834K +6,833 New
LMGAM
120
Liberty Mutual Group Asset Management
Massachusetts
$772K +$12.6K +103 +2%
Credit Agricole
121
Credit Agricole
France
$756K +$771K +6,312 New
Fifth Third Bancorp
122
Fifth Third Bancorp
Ohio
$747K -$23.8K -195 -3%
Tudor Investment Corp
123
Tudor Investment Corp
Connecticut
$712K +$36.6K +300 +5%
OPERF
124
Oregon Public Employees Retirement Fund
Oregon
$697K +$12.2K +100 +2%
Barclays
125
Barclays
United Kingdom
$684K -$599K -4,906 -46%
3 4
5
6 7

BIO Hedge Fund Activity: Q2 2014 in Review

204 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2014, worth a combined $2.2B — down 4.4% from $2.31B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new BIO positions and 22 closed out — a net gain of 11 holders — while 80 added to existing stakes and 57 trimmed.

The largest buyer was Norges Bank, adding an estimated $18.9M. The largest seller was Fidelity Investments, cutting an estimated $24.4M.

  • 204 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2014, up from 193 in Q1 2014.
  • Funds reported $2.2B of Bio-Rad Laboratories Class A stock for Q2 2014, down 4.4% quarter-over-quarter.
  • 33 funds opened new Bio-Rad Laboratories Class A positions in Q2 2014 and 22 closed out, a net change of +11 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q2 2014 was Norges Bank, an estimated $18.9M added.
  • The largest Bio-Rad Laboratories Class A seller in Q2 2014 was Fidelity Investments, an estimated $24.4M sold.

Based on aggregated 13F filings for Q2 2014.